Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and

Tharusha Gunawardena1, Ioannis Merinopoulos1, Upul Wickramarachchi1

  • 1Department of Cardiology, Norfolk and Norwich University Hospital, Colney Lane NR4 7UY, Norwich, United Kingdom.

Insights

Percutaneous coronary intervention advances treatment for coronary artery disease but often overlooks the microcirculation. Greater focus on coronary endothelium and microcirculation mechanisms can improve revascularization strategies.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) has transformed coronary artery disease (CAD) treatment by focusing on major epicardial arteries.
  • Current PCI strategies, despite evolving physiological assessments, frequently neglect the crucial role of the coronary microcirculation in patient prognosis.
  • The coronary microcirculation, often viewed as a simple conduit, possesses significant functional importance and influences cardiovascular outcomes.

Purpose of the Study:

  • To review the organization and physiology of the coronary circulation, highlighting its functional significance.
  • To examine current diagnostic methods and techniques for assessing the coronary microcirculation.
  • To discuss the impact of PCI on coronary artery endothelial function and the long-term consequences for the coronary microcirculation.

Main Methods:

  • Literature review of studies on coronary circulation organization, physiology, and assessment techniques.
  • Analysis of research on coronary artery endothelial function and the effects of PCI.
  • Exploration of the spectrum of coronary artery disease and its microcirculatory implications.

Main Results:

  • The coronary circulation is an organ with functional significance beyond mere blood conduction.
  • PCI can have latent effects on the coronary microcirculation, leading to long-term consequences.
  • Coronary artery disease involves a spectrum of disorders where microcirculatory dysfunction plays a key role.

Conclusions:

  • Enhanced understanding of the coronary artery endothelium and microcirculation mechanisms is essential.
  • Integrating microcirculatory assessment into PCI decision-making can optimize revascularization strategies.
  • Future research should focus on the functional role of the coronary microcirculation in CAD management.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
270
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
771
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
282
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
622
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
595
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
353